Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dolchem is a Polish chemical manufacturer specializing in high-purity intermediates and raw materials for the pharmaceutical, food, and healthcare industries. The company is a leading producer of pharmaceutical-grade glycine and various acetates, which are critical components in dialysis fluids and parenteral nutrition formulations. Operating under strict Good Manufacturing Practice (GMP) standards, Dolchem ensures its products meet the rigorous quality requirements of the global life sciences market. As a subsidiary of the PCC Group, the company provides essential chemical building blocks and contract manufacturing services to pharmaceutical companies worldwide. Their expertise in chemical synthesis allows them to support a wide range of applications, from medical treatments to specialized industrial processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DOLCHEM.